NIR and MR imaging supported hydrogel based delivery system for anti-TNF alpha probiotic therapy of IBD

Jelena M. Janjic; Ales Berlec; Christina Bagia; Lu S. Liu; Irenej Jeric; Michael Gach; Bratislav M. Janjic; Borut Strukelj

doi:10.1117/12.2213376

22 April 2016 NIR and MR imaging supported hydrogel based delivery system for anti-TNF alpha probiotic therapy of IBD

Jelena M. Janjic, Ales Berlec, Christina Bagia, Lu S. Liu, Irenej Jeric, Michael Gach, Bratislav M. Janjic, Borut Strukelj

Author Affiliations +

Proceedings Volume 9723, Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications VIII; 972309 (2016) https://doi.org/10.1117/12.2213376
Event: SPIE BiOS, 2016, San Francisco, California, United States

Abstract

Current treatment of inflammatory bowel disease (IBD) is largely symptomatic and consists of anti-inflammatory agents, immune-suppressives or antibiotics, whereby local luminal action is preferred to minimize systemic side-effects. Recently, anti-TNFα therapy has shown considerable success and is now being routinely used. Here we present a novel approach of using perfluorocarbon (PFC) nanoemulsion containing hydrogels (nanoemulgels) as imaging supported delivery systems for anti-TNF alpha probiotic delivery in IBD. To further facilitate image-guided therapy a food-grade lactic acid bacterium Lactococcus lactis capable of TNFα-binding was engineered to incorporate infrared fluorescent protein (IRFP). This modified bacteria was then incorporated into novel PFC nanoemulgels. The nanoemulgels presented here are designed to deliver locally anti-TNFα probiotic in the lower colon and rectum and provide dual imaging signature of gel delivery (MRI) across the rectum and lower colon and bacteria release (NIR). NIR imaging data in vitro demonstrates high IRFP expressing and TNFα-binding bacteria loading in the hydrogel and complete release in 3 hours. Stability tests indicate that gels remain stable for at least 14 days showing no significant change in droplet size, zeta potential and pH. Flow cytometry analyses demonstrate the NIRF expressing bacteria L. lactis binds TNFα in vitro upon release from the gels. Magnetic resonance and near-infrared imaging in vitro demonstrates homogeneity of hydrogels and the imaging capacity of the overall formulation.

Citation Download Citation

Jelena M. Janjic, Ales Berlec, Christina Bagia, Lu S. Liu, Irenej Jeric, Michael Gach, Bratislav M. Janjic, and Borut Strukelj "NIR and MR imaging supported hydrogel based delivery system for anti-TNF alpha probiotic therapy of IBD", Proc. SPIE 9723, Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications VIII, 972309 (22 April 2016); https://doi.org/10.1117/12.2213376

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available